Optiver Holding
CGON icon

Optiver Holding’s CG Oncology CGON Stock Holding History

Optiver Holding’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1K Buy
311
+235
+309% +$15.4K ﹤0.01% 1483
2026
Q1 		$5.14K Sell
76
-18
-19% -$1.02K ﹤0.01% 1408
2025
Q4 		$3.9K Sell
94
-350
-79% -$14.5K ﹤0.01% 1551
2025
Q3 		$17.9K Buy
+444
New +$12.9K ﹤0.01% 1004

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Optiver Holding's CGON Position: Q2 2026 in Review

Optiver Holding increased its CG Oncology (CGON) stake by 309% in Q2 2026, buying an estimated $15.4K and bringing the position to 311 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1483.

Optiver Holding first reported a position in CGON in Q3 2025 and has held it in 4 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Optiver Holding held 311 shares of CG Oncology worth $22.1K as of Q2 2026.
  • Optiver Holding bought 235 CG Oncology shares in Q2 2026, an estimated $15.4K.
  • CG Oncology made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1483 holding.
  • Optiver Holding first reported a position in CG Oncology in Q3 2025 and has held it in 4 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.